Entrada Therapeutics Inc Asset Turnover Ratio (TRDA), as of first quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Entrada Therapeutics Inc   (NASDAQ: TRDA)
 

Entrada Therapeutics Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Entrada Therapeutics Inc 's asset turnover ratio, the ratio that measures the ability of Entrada Therapeutics Inc 's assets to generate revenue, sequentially decreased to 0.01 in the first quarter (Mar 31 2026), which does not come as a surprise, as the Entrada Therapeutics Inc continue to experience difficult business climate.

Within sector 183 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the First Quarter 2026 compared to the preceding quarter from 2630 to 3664.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

TRDA Asset Turnover Ratio (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Asset Change -31.03 % -16.69 % -13.82 % -10.76 % 13.35 %
Y / Y Revenue Change -95.74 % -96.53 % -91.75 % -97.94 % -65.23 %
Asset Turnover Ratio (TTM) 0.01 0.06 0.14 0.17 0.36
TRDA's Total Ranking # 3664 # 2630 # 2724 # 0 # 0
Seq. Asset Change -11.09 % -8.6 % -8 % -7.75 % 7.4 %
Seq. Revenue Change -32.64 % -19.52 % -17.23 % -90.51 % -45.03 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 184
Healthcare Sector # 533
Overall Market # 3664

Asset Turnover Ratio Statistics
High Average Low
0.47 0.25 0.01
(Jun 30 2024)   (Mar 31 2026)




TRDA Company Profile • Back to TRDA Efficiency Comparisons • Compare TRDA Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Mar 31 2026 Assets at quarter ending Mar 31 2026
Astrotech Corp  0.05 $ 1.008  Millions$ 21.525  Millions
Aclaris Therapeutics Inc   0.05 $ 8.367  Millions$ 180.965  Millions
Camp4 Therapeutics Corporation  0.04 $ 3.934  Millions$ 90.234  Millions
X4 Pharmaceuticals Inc  0.04 $ 9.014  Millions$ 207.366  Millions
Catheter Precision Inc   0.04 $ 1.108  Millions$ 25.495  Millions
Instil Bio Inc   0.04 $ 8.968  Millions$ 211.676  Millions
EBR Systems, Inc.  0.04 $ 3.979  Millions$ 99.358  Millions
Bridgebio Oncology Therapeutics Inc   0.04 $ 15.288  Millions$ 387.053  Millions
Solana Company  0.04 $ 9.589  Millions$ 247.113  Millions
Mountain Crest Acquisition Corp V  0.04 $ 0.041  Millions$ 1.101  Millions
Blue Water Vaccines Inc  0.04 $ 0.735  Millions$ 19.639  Millions
Tscan Therapeutics Inc   0.04 $ 9.136  Millions$ 247.892  Millions
Kymera Therapeutics Inc   0.04 $ 51.476  Millions$ 1,411.235  Millions
Pluri Inc   0.03 $ 1.079  Millions$ 32.252  Millions
Vivos Inc  0.03 $ 0.078  Millions$ 2.472  Millions
Bioage Labs Inc   0.03 $ 10.316  Millions$ 329.945  Millions
Newamsterdam Pharma Company N v   0.03 $ 22.565  Millions$ 775.867  Millions
Tao Synergies Inc   0.03 $ 0.688  Millions$ 23.758  Millions
Dbv Technologies S a   0.03 $ 5.783  Millions$ 209.755  Millions
Northwest Biotherapeutics Inc  0.03 $ 1.497  Millions$ 55.374  Millions
Onkure Therapeutics Inc   0.03 $ 2.816  Millions$ 104.929  Millions
Atrium Therapeutics Inc   0.03 $ 36.817  Millions$ 1,438.386  Millions
Eyepoint Inc   0.03 $ 7.614  Millions$ 301.264  Millions
Mangoceuticals Inc   0.02 $ 0.415  Millions$ 16.978  Millions
Uniqure N v   0.02 $ 18.093  Millions$ 769.222  Millions
Co diagnostics Inc   0.02 $ 0.718  Millions$ 34.362  Millions
Fate Therapeutics Inc   0.02 $ 6.316  Millions$ 329.789  Millions
Bioxcel Therapeutics Inc   0.02 $ 0.680  Millions$ 37.381  Millions
Vistagen Therapeutics Inc   0.02 $ 1.269  Millions$ 70.690  Millions
Anteris Technologies Global Corp   0.02 $ 1.851  Millions$ 108.593  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.